Table 1

Clinical and laboratory features of 12 patients with Kawasaki disease who presented during the SARS-CoV-2 pandemic

Patient No123456789101112
Complete KDIncomplete KD
Age, ethnicityInfant, LatinInfant, CaucasianInfant, CaucasianToddler, CaucasianToddler, CaucasianToddler, CaucasianChild, CaucasianInfant, AsianToddler, CaucasianToddler, BlackAdolescent, CaucasianAdolescent, Caucasian
Symptoms prior to diagnosis
 Duration (days)645575477477
 RespiratoryNoNoNoNoYesNoNoNoNoYesNoNo
 GastrointestinalNoYesNoYesYesYesYesYesYesYesYesYes
 NeurologicalNoYesNoYesNoNoYesYesNoYesNoNo
KD signs at diagnosis
 ConjunctivitisYesYesYesYesYesYesYesNoNoNoYesYes
 Erythema mouth/pharynxYesYesYesYesYesYesYesNoYesYesNoNo
 Polymorphous rashYesYesYesYesYesYesYesNoYesYesYesYes
 LymphadenopathyYesYesYesYesYesNoYesYesYesNoYesYes
 Erythema of the palms/solesYesNoYesYesYesYesYesYesYesYesNoNo
Contact with SARS-CoV-2 caseNoNoNoNoNoNoNoNoNoYesNoYes
SARS-CoV-2 RT-PCR in respiratory sample/stoolsNEG/NDNEG/POSNEG/NEGNEG/NEGNEG/NDNEG/NEGNEG/NEGNEG/NEGNEG/NDPOS/NDPOS/NDPOS/ND
SARS-CoV-2 IgGNEGPOSNEGNEGNEGPOSPOSNEGNEGPOSPOSPOS
CRP (normal <15 mg/L)18473464233165173128133229276241
PCT (normal <0.5 ng/mL)0.083.10.110.210.146.756.70.510.074.653.972.11
Ferritin (normal <120 ng/mL)114358664509667604219142563>20001424
ESR (normal <15 mm/hour)831443223639246193976
NT pro-BNP (normal <200 ng/L)1416647178291457799445103628344484029305500
Platelet count (normal 150–400×109/L)44912937312950929614924945617011776
LymphopeniaNoYesYesYesYesYesYesNoNoNoYesYes
TreatmentIVIG followed by IVIG+mPDNIVIG+mPDNIVIGIVIGIVIGIVIGIVIG+mPDNIVIG+mPDNIVIG followed by IVIG+mPDNIVIGmPDNNone
Length of stay (days)56523481281036
  • CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; IVIG, intravenous immunoglobulin; KD, Kawasaki disease; mPDN, methylprednisolone; ND, not done; NEG, negative; NT pro-BNP, N-terminal pro-brain natriuretic peptide; PCT, procalcitonin; POS, positive; RT-PCR, real-time PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.